BCYC · ISSUER CIK 1761612
BICYCLE THERAPEUTICS PLC
Between Aug 1, 2026 and Oct 29, 2026, 6 BICYCLE THERAPEUTICS PLC insiders reported $0.00 of open-market purchases and $63K of sales on SEC Form 4.
↗6 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 6 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$63KInsider selling
−$63KNet open-market
Oct 6, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 202616:45 | Oct 2, 2026 | BCYC | Director | S · Sell | $3.47 | −3,431 | 15,782 | -18% | −$12K | ||
| Oct 6, 202616:45 | Oct 5, 2026from Oct 2, 2026 | BCYC | CHIEF SCIENTIFIC OFFICER | S · Sell | $3.49 | −2,445 | 154,726 | -2% | −$9K | ||
| Oct 6, 202616:45 | Oct 5, 2026from Oct 2, 2026 | BCYC | CHIEF PROD & SUPPLY CHAIN OFF | S · Sell | $3.48 | −1,814 | 92,561 | -2% | −$6K | ||
| Oct 6, 202616:45 | Oct 5, 2026from Oct 2, 2026 | BCYC | Chief Operating Officer | S · Sell10b5-1 | $3.54 | −1,500 | 89,552 | -2% | −$5K | ||
| Oct 6, 202616:45 | Oct 5, 2026from Oct 2, 2026 | BCYC | CHIEF EXECUTIVE OFFICER, Director | S · Sell | $3.49 | −7,805 | 595,866 | -1% | −$27K | ||
| Oct 6, 202616:34 | Oct 5, 2026from Oct 2, 2026 | BCYC | Chief Financial Officer | S · Sell | $3.48 | −972 | 64,449 | -1% | −$3K |